Company

Curocell

Biotechnology Research Daejeon, Daejeon Gwang'yeogsi, Kr 26 employees

Employees: 26
Contacts: 1
Emails: 1

www.curocellbtx.com LinkedIn

Curocell Overview

Headquarters: Daejeon, Daejeon Gwang'yeogsi, Kr
Website: www.curocellbtx.com
Industry: Biotechnology Research
Employees: 26
Founded: 2016
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

CAR-T Immune cell therapy T cell

About Curocell

Curocell is a cell therapy company that discovers and develops CAR-T therapies for cancer. The company's current efforts focus on unleashing the body’s immune system through broad-spectrum CAR-T technologies to treat blood cancers, as well as solid cancers. The company's programmed T cell product candidates are differentiated by incorporation of T cell modifying technology designed to effectively overcoming the immune suppression, and thereby offers greater efficacy compared to the current CAR-T cell technology.

Curocell Contact Details

People in AeroLeads: 4
With contact data: 1
Email contacts: 1; 25.0% coverage

Curocell Org Chart

Sample employees and titles

Name	Title	Location	Contact
Hyeun Jin SEO	Bio Product Development, Team Manager	South Korea, Korea, Republic of	View
Joonmo Koo	Quality Assurance	South Korea, Korea, Republic of	View
Donghyuk Jeon	Director of Production Engineering		View
Chan Hyuk Kim	Professor at Seoul National University	South Korea, Korea, Republic of	Email